MIT-Pfizer Groundbreaking
Aiming for breakthroughs in the fight against Alzheimer’s disease, diabetes and other major illnesses, MIT and the pharmaceutical firm Pfizer Inc. held a formal groundbreaking for a new, multidisciplinary research center to be built on MIT property in the Kendall Square neighborhood.
The two-building complex will house Pfizer’s Cardiovascular, Metabolic, and Endocrine Diseases (CVMED) and Neuroscience research units. It will be situated within a couple of blocks of several MIT biomedical centers that conduct research related to Pfizer’s areas of drug development.
credit
Melanie Gonick
